The Beckwith-Wiedemann syndrome. The exomphalos-macroglossia-gigantism syndrome.
D000015:Abnormalities, Multiple / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D001786:Blood Glucose / Q000032:analysis; D001925:Brain Damage, Chronic / Q000517:prevention & control; D003409:Congenital Hypothyroidism; D003937:Diagnosis, Differential; D005260:Female; D005877:Gigantism / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D006554:Hernia, Umbilical / Q000151:congenital / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D006801:Humans; D007003:Hypoglycemia / Q000188:drug therapy; D007037:Hypothyroidism / Q000175:diagnosis; D007223:Infant; D008297:Male; D010672:Phenytoin / Q000627:therapeutic use; D011230:Precancerous Conditions; D013395:Sucrose / Q000627:therapeutic use; D013577:Syndrome; D014059:Tongue / Q000002:abnormalities
D001786:Blood Glucose; D013395:Sucrose; D010672:Phenytoin